Canaccord Financial Inc. (CF.TO) 12.68 $CF.TO
Canaccord Genuity expands equity research group with addition to its US biotechnology practice
PR Newswire - Thu Jul 31, 5:25PM CDT
Canaccord Genuity is pleased to announce that Marko Kozul, M.D. has agreed to join its Equity Research team as a Managing Director covering biotechnology companies.
Media Advisory: Access to Quarterly and Year-end Results Information
CNW Group - Wed Jul 23, 8:55AM CDT
Canaccord Genuity Group Inc. (TSX: CF, LSE: CF.) is scheduled to release its fiscal first quarter 2015 earnings results and supplementary financial information on Tuesday, August 5, 2014 after TSX market close. Interested investors, the media and other stakeholders may review the earnings release and supplementary financial information at www.canaccordgenuitygroup.com.
Canaccord Genuity Group Inc. Discloses Total Voting Rights
CNW Group - Fri Jul 04, 1:00AM CDT
Canaccord Genuity Group Inc. (the "Company"
(TSX: CF, LSE: CF.) announces that, for the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules, as at June 30, 2014, the total number of common shares in issue was 101,982,938 with each share carrying the right to one vote. This total may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
Canaccord Genuity Group Inc. Notice of AGM and Annual Information Filings
CNW Group - Thu Jun 26, 4:46PM CDT
Canaccord Genuity Group Inc. (TSX: CF, LSE: CF.) wishes to announce that the following documents have been filed with SEDAR (www.sedar.com) and posted to the National Storage Mechanism in the United Kingdom:
Canaccord Genuity Group Inc. announces nomination of independent Director
CNW Group - Tue Jun 24, 10:11AM CDT
Kalpana Desai nominated as Director for election at upcoming annual general meeting
Canaccord Genuity Group Inc. to be added to S&P/TSX Composite Index
CNW Group - Wed Jun 18, 11:50AM CDT
Canaccord Genuity Group Inc. ("Canaccord Genuity" (TSX: CF, LSE: CF.) announces that S&P Dow Jones Canadian Index Services has confirmed Canaccord Genuity will be added to the S&P/TSX Composite Index after the close of trading on Friday, June 20, 2014.
S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices
CNW Group - Fri Jun 13, 4:15PM CDT
Results of the Quarterly Review of the S&P/TSX Composite Index
Canaccord Genuity expands Equity Research group with addition to its healthcare practice
PR Newswire - Thu Jun 05, 10:05AM CDT
Canaccord Genuity is pleased to announce the expansion of its Healthcare Equity Research team with the hiring of Corey Davis, Ph.D., as a Managing Director covering Specialty Pharmaceuticals, with a focus in certain therapeutics areas within the biotech sector.
Canaccord Genuity Group Inc. reports record annual revenue for 2014
CNW Group - Tue Jun 03, 3:22PM CDT
Excluding significant items, fourth quarter diluted earnings per share of $0.25((1) )driven by performance of US and UK operations
Canaccord Genuity Group Inc. discloses total voting rights
CNW Group - Mon Jun 02, 10:39AM CDT
Canaccord Genuity Group Inc. (the "Company" (TSX: CF, LSE: CF.) announces that, for the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules, as at May 31, 2014, the total number of common shares in issue was 100,982,528 with each share carrying the right to one vote. This total may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
Canaccord Genuity Group Inc. Announces Peter Brown to Step Down as Director and Honorary Chairman
CNW Group - Fri May 23, 3:01PM CDT
Canaccord Genuity Group Inc. ("Canaccord Genuity" (TSX: CF, LSE: CF.) wishes to announce that effective May 23, 2014, Peter Brown has resigned as a director and officer of the company and will not be seeking re-election to the board of directors at the upcoming 2014 Annual General Meeting of shareholders.
Canaccord Genuity expands equity research group with additions to its energy practice
PR Newswire - Tue May 20, 12:31PM CDT
Canaccord Genuity is pleased to announce two senior additions to the firm's US equity research group.
Canaccord Genuity Group Inc. discloses transaction in own shares under normal course issuer bid/buy-back programme, cancellation of shares and total voting rights
CNW Group - Tue Apr 01, 12:09PM CDT
Canaccord Genuity Group Inc. (the "Company" (TSX: CF, LSE: CF.) wishes to announce that for the period from March 28, 2014, to March 31, 2014, it purchased 45,600 of its common shares through the facilities of the TSX and alternative trading systems pursuant to the normal course issuer bid (NCIB)/buy-back programme announced on August 8, 2013.
Canaccord Genuity Group Inc. Announces Head of Canaccord Genuity Wealth in United Kingdom
PR Newswire - Wed Mar 26, 12:00PM CDT
Canaccord Genuity Group Inc. (the "Company" (TSX: CF, LSE: CF.) is pleased to announce that David Esfandi has joined the Company to become Chief Executive of Canaccord Genuity Wealth in the United Kingdom, subject to the required regulatory approvals. Stephen Massey will also be assuming the role of Chairman of the Canaccord Genuity Wealth Board in the UK. In addition, the Company announces Neil Darke's departure, effective immediately.
Canaccord Genuity Group Inc. discloses transaction in own shares under normal course issuer bid/buy-back programme
CNW Group - Mon Mar 17, 12:12PM CDT
Canaccord Genuity Group Inc. (the "Company" (TSX: CF, LSE: CF.) wishes to announce that on March 10, 2014, it purchased 4,200 of its common shares through the facilities of the TSX and alternative trading systems pursuant to the normal course issuer bid (NCIB)/buy-back programme announced on August 8, 2013.
Canaccord Genuity expands equity research group with addition to its US biotechnology practice
PR Newswire - Thu Jul 31, 5:25PM CDT
Canaccord Genuity is pleased to announce that Marko Kozul, M.D. has agreed to join its Equity Research team as a Managing Director covering biotechnology companies.
Media Advisory: Access to Quarterly and Year-end Results Information
CNW Group - Wed Jul 23, 8:55AM CDT
Canaccord Genuity Group Inc. (TSX: CF, LSE: CF.) is scheduled to release its fiscal first quarter 2015 earnings results and supplementary financial information on Tuesday, August 5, 2014 after TSX market close. Interested investors, the media and other stakeholders may review the earnings release and supplementary financial information at www.canaccordgenuitygroup.com.
Canaccord Genuity Group Inc. Discloses Total Voting Rights
CNW Group - Fri Jul 04, 1:00AM CDT
Canaccord Genuity Group Inc. (the "Company"
(TSX: CF, LSE: CF.) announces that, for the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules, as at June 30, 2014, the total number of common shares in issue was 101,982,938 with each share carrying the right to one vote. This total may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules. Canaccord Genuity Group Inc. Notice of AGM and Annual Information Filings
CNW Group - Thu Jun 26, 4:46PM CDT
Canaccord Genuity Group Inc. (TSX: CF, LSE: CF.) wishes to announce that the following documents have been filed with SEDAR (www.sedar.com) and posted to the National Storage Mechanism in the United Kingdom:
Canaccord Genuity Group Inc. announces nomination of independent Director
CNW Group - Tue Jun 24, 10:11AM CDT
Kalpana Desai nominated as Director for election at upcoming annual general meeting
Canaccord Genuity Group Inc. to be added to S&P/TSX Composite Index
CNW Group - Wed Jun 18, 11:50AM CDT
Canaccord Genuity Group Inc. ("Canaccord Genuity"
(TSX: CF, LSE: CF.) announces that S&P Dow Jones Canadian Index Services has confirmed Canaccord Genuity will be added to the S&P/TSX Composite Index after the close of trading on Friday, June 20, 2014. S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices
CNW Group - Fri Jun 13, 4:15PM CDT
Results of the Quarterly Review of the S&P/TSX Composite Index
Canaccord Genuity expands Equity Research group with addition to its healthcare practice
PR Newswire - Thu Jun 05, 10:05AM CDT
Canaccord Genuity is pleased to announce the expansion of its Healthcare Equity Research team with the hiring of Corey Davis, Ph.D., as a Managing Director covering Specialty Pharmaceuticals, with a focus in certain therapeutics areas within the biotech sector.
Canaccord Genuity Group Inc. reports record annual revenue for 2014
CNW Group - Tue Jun 03, 3:22PM CDT
Excluding significant items, fourth quarter diluted earnings per share of $0.25((1) )driven by performance of US and UK operations
Canaccord Genuity Group Inc. discloses total voting rights
CNW Group - Mon Jun 02, 10:39AM CDT
Canaccord Genuity Group Inc. (the "Company"
(TSX: CF, LSE: CF.) announces that, for the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules, as at May 31, 2014, the total number of common shares in issue was 100,982,528 with each share carrying the right to one vote. This total may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules. Canaccord Genuity Group Inc. Announces Peter Brown to Step Down as Director and Honorary Chairman
CNW Group - Fri May 23, 3:01PM CDT
Canaccord Genuity Group Inc. ("Canaccord Genuity"
(TSX: CF, LSE: CF.) wishes to announce that effective May 23, 2014, Peter Brown has resigned as a director and officer of the company and will not be seeking re-election to the board of directors at the upcoming 2014 Annual General Meeting of shareholders. Canaccord Genuity expands equity research group with additions to its energy practice
PR Newswire - Tue May 20, 12:31PM CDT
Canaccord Genuity is pleased to announce two senior additions to the firm's US equity research group.
Canaccord Genuity Group Inc. discloses transaction in own shares under normal course issuer bid/buy-back programme, cancellation of shares and total voting rights
CNW Group - Tue Apr 01, 12:09PM CDT
Canaccord Genuity Group Inc. (the "Company"
(TSX: CF, LSE: CF.) wishes to announce that for the period from March 28, 2014, to March 31, 2014, it purchased 45,600 of its common shares through the facilities of the TSX and alternative trading systems pursuant to the normal course issuer bid (NCIB)/buy-back programme announced on August 8, 2013. Canaccord Genuity Group Inc. Announces Head of Canaccord Genuity Wealth in United Kingdom
PR Newswire - Wed Mar 26, 12:00PM CDT
Canaccord Genuity Group Inc. (the "Company"
(TSX: CF, LSE: CF.) is pleased to announce that David Esfandi has joined the Company to become Chief Executive of Canaccord Genuity Wealth in the United Kingdom, subject to the required regulatory approvals. Stephen Massey will also be assuming the role of Chairman of the Canaccord Genuity Wealth Board in the UK. In addition, the Company announces Neil Darke's departure, effective immediately. Canaccord Genuity Group Inc. discloses transaction in own shares under normal course issuer bid/buy-back programme
CNW Group - Mon Mar 17, 12:12PM CDT
Canaccord Genuity Group Inc. (the "Company"
(TSX: CF, LSE: CF.) wishes to announce that on March 10, 2014, it purchased 4,200 of its common shares through the facilities of the TSX and alternative trading systems pursuant to the normal course issuer bid (NCIB)/buy-back programme announced on August 8, 2013. 
